MedPath
HSA Approval

TRAVOGEN CREAM 1%

SIN05333P

TRAVOGEN CREAM 1%

TRAVOGEN CREAM 1%

January 14, 1991

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.
Licence HolderDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CREAM

**Dosage and Administration** Cutaneous use. Travogen should be applied once daily to the affected areas of skin. A general rule for fungal infections is that topical therapy be continued for a period of two to three weeks, and for four weeks in refractory infections (particularly infections of the interdigital spaces). Longer period of treatment are also possible. To avoid recurrence, treatment should be continued for at least another two weeks after clinical healing.

TOPICAL

Medical Information

**Indications** Superficial fungal infections of the skin, e.g. in the region of the hands, the interdigital spaces of the feet, and in the inguinal and genital regions.

**Contraindications** None so far known.

D01AC05

isoconazole

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

LEO Pharma Manufacturing Italy S.r.I

Active Ingredients

ISOCONAZOLE NITRATE

10 mg/g

Isoconazole

Documents

Package Inserts

063330-XX_4.pdf

Approved: September 27, 2019

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRAVOGEN CREAM 1% - HSA Approval | MedPath